BROOKS Stock Overview
Manufactures and sells pharmaceuticals in India and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Brooks Laboratories Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹91.10 |
52 Week High | ₹185.70 |
52 Week Low | ₹57.50 |
Beta | 1.38 |
1 Month Change | -9.58% |
3 Month Change | -25.60% |
1 Year Change | 55.99% |
3 Year Change | -16.27% |
5 Year Change | 67.93% |
Change since IPO | 1,301.54% |
Recent News & Updates
Recent updates
Would Brooks Laboratories (NSE:BROOKS) Be Better Off With Less Debt?
Sep 28Does Brooks Laboratories (NSE:BROOKS) Have A Healthy Balance Sheet?
Jun 10Estimating The Intrinsic Value Of Brooks Laboratories Limited (NSE:BROOKS)
Feb 22Is Brooks Laboratories (NSE:BROOKS) Using Too Much Debt?
Dec 08Is Brooks Laboratories (NSE:BROOKS) A Risky Investment?
Jul 07Here's Why Brooks Laboratories (NSE:BROOKS) Can Afford Some Debt
Jan 05Brooks Laboratories (NSE:BROOKS) Is Making Moderate Use Of Debt
Sep 22Shareholder Returns
BROOKS | IN Life Sciences | IN Market | |
---|---|---|---|
7D | -5.1% | 2.4% | 3.0% |
1Y | 56.0% | 15.0% | 44.6% |
Return vs Industry: BROOKS exceeded the Indian Life Sciences industry which returned 15% over the past year.
Return vs Market: BROOKS exceeded the Indian Market which returned 44.6% over the past year.
Price Volatility
BROOKS volatility | |
---|---|
BROOKS Average Weekly Movement | 7.7% |
Life Sciences Industry Average Movement | 5.8% |
Market Average Movement | 6.5% |
10% most volatile stocks in IN Market | 9.5% |
10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: BROOKS's share price has been volatile over the past 3 months.
Volatility Over Time: BROOKS's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2002 | 296 | n/a | www.brookslabs.net |
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. It offers liquid and dry powder injection, carbapenem drugs, tablets, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
Brooks Laboratories Limited Fundamentals Summary
BROOKS fundamental statistics | |
---|---|
Market cap | ₹2.39b |
Earnings (TTM) | -₹195.92m |
Revenue (TTM) | ₹804.42m |
3.0x
P/S Ratio-12.2x
P/E RatioIs BROOKS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BROOKS income statement (TTM) | |
---|---|
Revenue | ₹804.42m |
Cost of Revenue | ₹566.09m |
Gross Profit | ₹238.33m |
Other Expenses | ₹434.25m |
Earnings | -₹195.92m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -7.46 |
Gross Margin | 29.63% |
Net Profit Margin | -24.36% |
Debt/Equity Ratio | 7.7% |
How did BROOKS perform over the long term?
See historical performance and comparison